Company Overview

Update
Headquarters:
Fremont, CA
Funding:
$28.30M
Categories:
Biotechnology

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

Description

Update

ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.

Funding Rounds (3) - $28.30M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    6300 Dumbarton Circle

    Fremont, CA 94555

    USA

Images (1)

Update
  • 3467b0dd227712eec2bb01d2995687e4